ISO 9001 
ISO 17100 
ISO 18587 LinguaVox provides biotechnology translation services for biotech firms, research centres, laboratories, investors and technology transfer teams. We manage multilingual projects in more than 150 languages, combining specialist translators, project management, terminology control and review workflows according to what each assignment requires.
Translation for the biotechnology sector
Biotechnology sits where science, regulation and business development meet, and its translation needs reflect all three. A single programme may generate laboratory protocols, a patent application, a grant submission, an investor presentation and a regulatory dossier — scientific, legal and commercial documents that must nonetheless use the same core terminology for the same molecules, methods and products. When that terminology drifts between a patent and a pitch deck, it creates confusion exactly where precision matters most.
For that reason we do not assign work on language pair alone. The document type, the target reader, the destination market, the format and the level of review all shape the workflow, and we confirm them before quoting.
Documents we translate
Typical documents include research summaries and scientific articles, laboratory protocols, technical dossiers, patent-related content, grant and funding applications, investor presentations and pitch materials, clinical development documents and product documentation. Some are highly confidential and pre-publication; others are public-facing. Some support intellectual property and must be precise to the word; others support fundraising and must also persuade. We match the translator and the level of review to each of these purposes rather than treating them as one category.
Before quoting, we review the files whenever possible to identify non-editable text, figures, embedded content, repetitions, versioning issues and instructions that should be applied during translation.
Specialist translators and quality control
Projects are assigned to translators with relevant scientific or technical experience and the right language combination. Where the assignment includes bilingual revision, a second qualified linguist checks the translation against the source, and the project manager reviews files, instructions and delivery format before completion. For patent-related and IP-sensitive content, accuracy and terminological discipline take priority, and we can work to your defined terminology from the first file.
This supports ISO 17100-based workflows for professional translation. For suitable, lower-risk content, full post-editing of machine translation may be considered, but IP, regulatory and investor-facing material is normally handled by human translation with revision.
Confidentiality and terminology
Biotech work is often confidential well before anything is published or filed. We can work under non-disclosure agreements where required and limit access to the assigned team. Alongside confidentiality, we keep a stable termbase and translation memory for each client so that the names of methods, compounds and products stay identical across scientific, legal and commercial documents and across every language version, which protects both clarity and intellectual property.
Languages, markets and delivery
Biotech language needs follow the science, the funding and the partners. English is almost always part of the picture, whether for publication, an international filing or a funding round, and it is frequently paired with German, French, Spanish, Japanese, Korean or Chinese depending on where research, investors and collaborators sit. We coordinate these combinations together and keep terminology aligned across all of them, which matters when the same compound or method appears in a paper, a patent and a pitch deck at once. We work with the formats this content arrives in — Word, Excel, PowerPoint, editable PDF, LaTeX-derived text, HTML and XML — and can return files ready for layout or submission. Where content is destined for patent filing or other legal use, we confirm whether a certified translation is required for the jurisdiction concerned and prepare it accordingly. For ongoing programmes we keep a structured set of memories and glossaries so that, as a project moves from the lab toward partnering or the clinic, its core terminology carries through every new document and language unchanged. This continuity is particularly useful in biotech, where small teams produce a steady stream of documents over several years and where a partner or investor will read across all of them, expecting one coherent description of the science.
Related services
Biotechnology translation frequently connects with pharmaceutical and clinical research translation, legal, patent and certified translation, technical translation, website localisation and terminology management. The right combination depends on the files and on how the content will be used.
How to request a quote
To prepare an accurate quote, send the files, the language combination, the deadline, the destination markets and the intended use, with any previous translations, glossaries or style preferences. For larger projects we can organise staged deliveries, separate files by language and keep a consistent structure across markets, so translation supports rather than delays your timelines.
Frequently asked questions
Can you keep terminology consistent across patents, science and pitch decks?
Yes. We build a termbase and translation memory so the names of compounds, methods and products are translated identically across technical, legal and commercial documents. This consistency matters most for biotech, where the same terms appear in patents, regulatory files and investor materials.
Do you handle confidential, pre-publication research?
Yes. We can work under non-disclosure agreements where required and restrict access to the translators and reviewers assigned to your project. Tell us about any specific confidentiality or data-handling requirements and we will confirm how we meet them before starting.
Can you translate patent and IP-related documents?
Yes. Patent-related content demands precise, consistent terminology, so we assign translators with the right background and prioritise accuracy and defined terminology. Where a certified translation is needed for filing or legal use, we confirm the required format for the destination jurisdiction.
Do you translate investor and fundraising material?
Yes. Investor presentations and pitch materials need to be accurate about the science and clear and persuasive for a non-specialist audience. We balance both, keeping technical terms consistent with your other documents while making the narrative read well in the target language.
Which languages do biotech clients usually need?
It varies with funding, partners and target markets, but English is almost always involved, alongside combinations such as German, French, Spanish, Japanese, Korean and Chinese. We coordinate several languages at once and keep terminology aligned across all of them.
